
Dr Andrew Ustianowski
Consultant, Infectious DiseasesProfessor Andrew Ustianowski is a distinguished Consultant Physician specializing in Infectious Diseases and Tropical Medicine at the Regional Infectious Diseases Unit, North Manchester General Hospital, part of the Manchester University NHS Foundation Trust (MFT).
Professional Roles and Contributions:
- National Institute for Health and Care Research (NIHR): Professor Ustianowski serves as the Interim Executive Director of the Research Delivery Network (RDN) at NIHR. He is also the Joint National Specialty Lead for Infection, overseeing research initiatives in infectious diseases across the UK. NIHR
- COVID-19 Research Leadership: As the Clinical Lead for the NIHR COVID Vaccine Research Programme, he has played a pivotal role in guiding national vaccine research efforts. He has been the UK Chief Investigator on multiple COVID-19 studies, contributing significantly to the understanding and management of the pandemic. bsac.org.uk
- Academic Background: Professor Ustianowski graduated from Guy’s Hospital, London, and underwent specialized training in Infectious Diseases, Tropical Medicine, HIV, and General Medicine within the London region.
Contributions to research
- Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial. Lancet Infect Dis. 2025 Jan;25(1):68-79. doi: 10.1016/S1473-3099(24)00431-6.
- Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients. Mozaffari E, Chandak A, Ustianowski A, Rivera CG, Ahuja N, Jiang H, Berry M, Okulicz JF, Amin AN.Clin Ther. 2024 Oct;46(10):778-784. doi: 10.1016/j.clinthera.2024.08.004.
- Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom. Ko S, Dominguez-Dominguez L, Ottaway Z, Campbell L, Fox J, Burns F, Hamzah L, Ustianowski A, Clarke A, Kegg S, Schoeman S, Jones R, Pett SL, Hudson J, Post FA.HIV Med. 2024 Dec;25(12):1289-1297. doi: 10.1111/hiv.13706. Epub 2024 Aug 29.PMID: 39209512
His extensive experience and leadership have been instrumental in advancing research and treatment strategies in infectious diseases, particularly during the COVID-19 pandemic.
Telephone: 0161 922 3822
GMC: 3546703